These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8542651)

  • 1. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients.
    Beaudeux JL; Guillausseau PJ; Peynet J; Flourie F; Assayag M; Tielmans D; Warnet A; Rousselet F
    Clin Chim Acta; 1995 Aug; 239(2):131-41. PubMed ID: 8542651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects.
    Leonhardt W; Hanefeld M; Müller G; Hora C; Meissner D; Lattke P; Paetzold A; Jaross W; Schroeder HE
    Clin Chim Acta; 1996 Oct; 254(2):173-86. PubMed ID: 8896905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus.
    Anderson JW; Gowri MS; Turner J; Nichols L; Diwadkar VA; Chow CK; Oeltgen PR
    J Am Coll Nutr; 1999 Oct; 18(5):451-61. PubMed ID: 10511327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes.
    Tan KC; Ai VH; Chow WS; Chau MT; Leong L; Lam KS
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3212-6. PubMed ID: 10487689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation.
    Belkebir-Mesbah D; Bonnefont-Rousselot D; Frey-Fressart V; Moinard C; Delattre J; Vasson MP
    Endocrine; 1999 Jun; 10(3):233-42. PubMed ID: 10484287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation.
    Moro E; Zambon C; Pianetti S; Cazzolato G; Pais M; Bittolo Bon G
    Acta Diabetol; 1998 Oct; 35(3):161-4. PubMed ID: 9840454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
    Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
    Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).
    Calò L; Sartore G; Bassi A; Basso C; Bertocco S; Marin R; Zambon S; Cantaro S; D'Angelo A; Davis PA; Manzato E; Crepaldi G
    J Hypertens; 1998 Jul; 16(7):1001-8. PubMed ID: 9794741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients.
    Jain SK; McVie R; Jaramillo JJ; Chen Y
    Free Radic Biol Med; 1998 Jan; 24(1):175-81. PubMed ID: 9436628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach.
    Kontush A; Hübner C; Finckh B; Kohlschütter A; Beisiegel U
    Free Radic Res; 1996 Feb; 24(2):135-47. PubMed ID: 8845914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of low-density lipoprotein in normotensive type 2 diabetic patients. Comparative effects of enalapril versus nifedipine: a randomized cross-over over study.
    Rachmani R; Lidar M; Brosh D; Levi Z; Ravid M
    Diabetes Res Clin Pract; 2000 May; 48(2):139-45. PubMed ID: 10802151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.
    Liguori A; Abete P; Hayden JM; Cacciatore F; Rengo F; Ambrosio G; Bonaduce D; Condorelli M; Reaven PD; Napoli C
    Eur Heart J; 2001 Nov; 22(22):2075-84. PubMed ID: 11686665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
    Julier K; Mackness MI; Dean JD; Durrington PN
    Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients.
    Merzouk S; Hichami A; Sari A; Madani S; Merzouk H; Yahia Berrouiguet A; Lenoir-Rousseaux JJ; Chabane-Sari N; Khan NA
    Gen Physiol Biophys; 2004 Dec; 23(4):387-99. PubMed ID: 15815074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
    Jialal I; Grundy SM
    Circulation; 1993 Dec; 88(6):2780-6. PubMed ID: 8252691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition.
    Dimitriadis E; Griffin M; Owens D; Johnson A; Collins P; Tomkin GH
    Diabetologia; 1995 Nov; 38(11):1300-6. PubMed ID: 8582539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples.
    Diwadkar VA; Anderson JW; Bridges SR; Gowri MS; Oelgten PR
    Proc Soc Exp Biol Med; 1999 Nov; 222(2):178-84. PubMed ID: 10564543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein.
    Geetha A; Surendran R
    Pharmazie; 2005 Aug; 60(8):609-13. PubMed ID: 16124405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification.
    Sánchez-Quesada JL; Pérez A; Caixàs A; Rigla M; Payés A; Benítez S; Ordóñez-Llanos J
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3243-9. PubMed ID: 11443196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.